Ligand-independent androgen receptor antagonism caused by the newly developed pesticide pyrifluquinazon (PFQ)

Reproductive Toxicology

Volumn 35, Issue 1, 2013, Pages 1-6

  Yasunaga, Ryoko ^a   Ikuta, Junko ^a   Murata, Yohei ^a   Inoue, Kazuyoshi ^a   Koga, Hiroyasu ^a   Masaki, Takao ^a   Tamura, Hiroto ^b  

^a NIHON NOHYAKU CO LTD   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Androgen receptor; Antiandrogen; Ligand binding; Pesticide; Pyrifluquinazon

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; PESTICIDE; PYRIFLUQUINAZON; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LEVEL; COMPETITIVE INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT;

RATTUS;

EID: 84872419232     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2012.11.001     Document Type: Article

References (32)

1. Masiello D., Cheng S., Bubley G.J., Lu M.L., Balk S.P. Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. Journal of Biological Chemistry 2002, 277:26321-26326.
2. Koivisto P., Kononen J., Palmberg C., Tammela T., Hyytinen E., Isola J., et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Research 1997, 57:314-319.
3. Yeh S., Sampson E.R., Lee D.K., Kim E., Hsu C.L., Chen Y.L., et al. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer. Journal of the Formosan Medical Association 2000, 99:885-894.
4. Lambright C., Ostby J., Bobseine K., Wilson V., Hotchkiss A.K., Mann P.C., et al. Cellular and molecular mechanisms of action of linuron: an antiandrogenic herbicide that produces reproductive malformations in male rats. Toxicological Sciences 2000, 56:389-399.
5. Kelce W.R., Stone C.R., Laws S.C., Gray L.E., Kemppainen J.A., Wilson E.M. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature 1995, 375:581-585.
6. Cynthia A.H., Chawnshang C. Androgen receptor (AR) coregulators: An overview. Endocrine Reviews 2002, 23:175-200.
7. Harada N., Ohmori Y., Yamaji R., Higashimura Y., Okamoto K., Isohashi F., et al. ARA24/Ran enhances the androgen-dependent NH2- and COOH-terminal interaction of the androgen receptor. Biochemical and Biophysical Research Communications 2008, 373:373-377.
8. Hodgson M.C., Astapova I., Hollenberg A.N., Balk S.P. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Cancer Research 2007, 67:8388-8395.
9. Sunami O., Kunimatsu T., Yamada T., Yabushita S., Sukata T., Miyata K., et al. Evaluation of a 5-day Hershberger assay using young mature male rats: methyltestosterone and p,p'-DDE, but not fenitrothion, exhibited androgenic or antiandrogenic activity in vivo. Journal of Toxicological Sciences 2000, 25:403-415.
10. Yamada T., Kunimatsu T., Sako H., Yabushita S., Sukata T., Okuno Y., et al. Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity. Toxicological Sciences 2000, 53:289-296.
11. Karvonen U., Kallio P.J., Janne O.A., Palvimo J.J. Interaction of androgen receptors with androgen response element in intact cells. Roles of amino- and carboxyl-terminal regions and the ligand. Journal of Biological Chemistry 1997, 272:15973-15979.
12. Moilanen A., Rouleau N., Ikonen T., Palvimo J.J., Janne O.A. The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells. FEBS Letters 1997, 412:355-358.
13. Wilson V.S., Bobseine K., Lambright C.R., Gray L.E. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicological Sciences 2002, 66:69-81.
14. EDSP test guideline, OPPTS 890.1150: Androgen Receptor Binding. (Rat Prostate Cytosol). EPA 2009.
15. OECD guideline for the testing of chemicals " the Hershberger bioassay in rats" OECD 2009.
16. Olsson P.E., Berg A.H., Hofsten J.V., Grahn B., Hellqvist A., Larsson A., et al. Molecular cloning and characterization of a nuclear androgen receptor activated by 11-ketotestosterone. Reproductive Biology and Endocrinology 2005, 3:1-17.
17. Paris F., Balaguer P., Terouanne B., Servant N., Lacoste C., Cravedi J.P., et al. Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit α and β estrogen activities and antiandrogen activity in reporter cell lines. Molecular and Cellular Endocrinology 2002, 193:43-49.
18. Ikonen T., Palvimo J.J., Janne O.A. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. Journal of Biological Chemistry 1997, 272:29821-29828.
19. Cha T.L., Qiu L., Chen C.T., Wen Y., Hung M.C. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Research 2005, 65:2287-2295.
20. Chen L., Meng S., Wang H., Bali P., Bai W., Li B., et al. Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824. Molecular Cancer Therapy 2005, 4:1311-1319.
21. Vanaja D.K., Mitchell S.H., Toft D.O., Young C.Y. Effect of geldanamycin on androgen receptor function and stability. Cell Stress and Chaperones 2002, 7:55-64.
22. Jones J.O., Bolton E.C., Huang Y., Feau C., Guy R.K., Yamamoto K.R., et al. Non-competitive androgen receptor inhibition in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:7233-7238.
23. Caboni L., Kinsella G.K., Blanco F., Fayne D., Jagoe W.N., Carr M., et al. " True" antiandrogens-selective non-ligand-binding pocket disruptors of androgen receptor-coactivator interactions: novel tools for prostate cancer. Journal of Medicinal Chemistry 2012, 55:1635-1644.
24. Claessens F., Denayer S., Tiborgh N.V., Kerkhofs S., Helsen C., Haelens A. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nuclear Receptor Signalling 2008, 6:1-13.
25. Chang C.S., Kokontis J., Liao S.T. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proceedings of the National Academy of Sciences of the United States of America 1988, 85:7211-7215.
26. Betney R., McEwan I.J. Role of conserved hydrophobic amino acids in androgen receptor AF-1 function. Journal of Molecular Endocrinology 2003, 31:427-439.
27. Bevan C.L., Hoase S., Claessens F., Heery D.M., Parler M.G. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Molecular and Cellular Biology 1999, 19:8383-8389.
28. Callewaert L., Verrijdt G., Christiaens V., Haelens A., Claesens F. Dual function of an amino-terminal amphipatic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements. Journal of Biological Chemistry 2003, 278:8212-8218.
29. Aït-Aïssa S., Laskowski S., Laville N., Porcher J.M., Brion F. Anti-androgenic activities of environmental pesticides in the MDA-kb2 reporter cell line. Toxicology In Vitro 2010, 24:1979-1985.
30. Nishizaki Y., Ishimoto Y., Hotta Y., Hosoda A., Yoshikawa H., Akamatsu M., et al. Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay. Bioorganic and Medicinal Chemistry Letters 2009, 19:4706-4710.
31. Ma H., Hong H., Huang S.M., Irvine R.A., Webb P., Kushner P.J., et al. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. Molecular and Cellular Biology 1999, 19:6164-6173.
32. Chamberlain N.L., Whitacre D.C., Miesfeld R.L. Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. Journal of Biological Chemistry 1996, 271:26772-26828.